Skip to main content
NIH funding notice PAR-16-351

Conference for Early Stage HIV/AIDS Vaccine Researchers (R13)

Closed on September 6, 2016.

Posted
June 30, 2016
Close date
September 6, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $74,999 in first-year total cost, median $74,999.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IMST-C (90)]1

Most frequent institutions

  1. FRED HUTCHINSON CANCER RESEARCH CENTER1
Competing awards under PAR-16-351 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Annual Conference For Early Stage HIV/AIDS Vaccine Researchers1R13OD024033-01KUBLIN, JAMES G.FRED HUTCHINSON CANCER RESEARCH CENTER, WA$74,999ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-16-351: Conference for Early Stage HIV/AIDS Vaccine Researchers (R13) | ScienceDex | ConductScience